FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Everolimus 2mg dispersible tablets sugar free Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 2g/20ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 22.5mg/0.9ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 2g powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 600mg/24ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Topotecan 1mg/1ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon alfa-2b (rbe) 18million units/1.2ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Doxorubicin 20mg/10ml solution for infusion pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pazopanib 400mg tablets Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Doxorubicin 45mg/22.5ml solution for infusion pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 1650mg/105ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 17.5mg/0.7ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Aldesleukin 18million unit powder for solution for injection vials Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carmustine 100mg powder and solvent for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Busulfan 25mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 20mg/0.4ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 12mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 4mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dacarbazine 500mg powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Lapatinib 250mg tablets Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Generic Rebif initiation pack Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 20mg/1ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 10mg/0.4ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 75mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 200mg/2ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vincristine 1mg/1ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Trastuzumab 420mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 27.5mg/0.55ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 1026mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Hydroxycarbamide 500mg/5ml oral solution sugar free Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Megestrol 10mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Axitinib 7mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 18mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 30mg/1.5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Doxorubicin 5mg/2.5ml solution for infusion pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Peginterferon beta-1a 94micrograms/0.5ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Peginterferon alfa-2a 135micrograms/0.5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 200mg/5ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cetuximab 100mg/20ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Tasonermin 1mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Chlorambucil 5mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 1.5g powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bortezomib 2.5mg/1ml in Sodium chloride 0.9% solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Leuprorelin 11.25mg powder and solvent for suspension for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cisplatin 128mg/1000ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bortezomib 2.25mg/0.9ml in Sodium chloride 0.9% solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon alfa-2b (rbe) 10million unit powder and solvent for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Temoporfin 3mg/3ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ceritinib 150mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Peginterferon alfa-2b (rbe) 100microgram powder and solvent for solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dasatinib 80mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon alfa-2b (rbe) 60million units/1.2ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cytarabine 5g/50ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ruxolitinib 10mg tablets Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Leuprorelin 22.5mg powder and solvent for suspension for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 3500mg/300ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vincristine 2mg/2ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Clofarabine 20mg/20ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bortezomib 2mg/0.8ml in Sodium chloride 0.9% solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 25mg/1.25ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 10mg/0.2ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Oxaliplatin 250mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cisplatin 50mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 7mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bicalutamide 150mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Megestrol 80mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Doxorubicin 10mg/2ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 2394mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dasatinib 10mg/ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 1g/25ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Epirubicin 60mg/30ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 17.5mg/0.7ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon beta-1a 6million units/0.5ml solution for injection 1.5ml cartridges Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Lenalidomide 25mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Irinotecan 330mg/220ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Irinotecan 300mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bendamustine 25mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 12mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 2500mg/105ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cetuximab 500mg/100ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Doxorubicin 50mg/25ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Amsacrine 75mg/1.5ml solution for infusion ampoules and diluent Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Topotecan 250microgram capsules Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Irinotecan 270mg/180ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 1254mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Afatinib 20mg tablets Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Idarubicin 5mg/5ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 1368mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 5mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 7.5mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bendamustine 100mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon beta-1a 30microgram powder and solvent for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vemurafenib 240mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mercaptopurine 75mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 1g solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 75mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 1.1g/44ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 2400mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon beta-1a 6million units/0.5ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vinblastine 12mg/50ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 22 of 26 Next End

This concept is not in any reference sets

Back to Start